Alpha DNA Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,222
| Closed | -$1.12M | – | 106 |
|
|
2024
Q4 | $1.12M | Sell |
11,222
-6,598
| -37% | -$656K | 0.43% | 43 |
|
|
2024
Q3 | $2.02M | Buy |
17,820
+1,254
| +8% | +$142K | 0.76% | 22 |
|
|
2024
Q2 | $2.05M | Sell |
16,566
-7,034
| -30% | -$871K | 0.8% | 22 |
|
|
2024
Q1 | $3.11M | Buy |
23,600
+5,450
| +30% | +$719K | 1.15% | 6 |
|
|
2023
Q4 | $1.98M | Buy |
18,150
+6,263
| +53% | +$683K | 0.77% | 20 |
|
|
2023
Q3 | $1.22M | Sell |
11,887
-15,971
| -57% | -$1.64M | 0.5% | 36 |
|
|
2023
Q2 | $3.21M | Buy |
27,858
+15,753
| +130% | +$1.82M | 1.07% | 6 |
|
|
2023
Q1 | $1.29M | Buy |
12,105
+862
| +8% | +$91.7K | 0.38% | 57 |
|
|
2022
Q4 | $1.25M | Sell |
11,243
-3,777
| -25% | -$419K | 0.44% | 57 |
|
|
2022
Q3 | $1.29M | Buy |
15,020
+12,787
| +573% | +$1.1M | 1.07% | 15 |
|
|
2022
Q2 | $203K | Buy |
+2,233
| New | +$203K | 0.17% | 112 |
|
|
2021
Q2 | – | Sell |
-3,113
| Closed | -$229K | – | 429 |
|
|
2021
Q1 | $229K | Buy |
3,113
+323
| +12% | +$23.8K | 0.26% | 101 |
|
|
2020
Q4 | $217K | Buy |
+2,790
| New | +$217K | 0.23% | 101 |
|